YVES SAINT LAURENT ALL HOURS FOUNDATION FLAWLESS COVERAGE BROAD SPECTRUM SPF 20 SUNSCREEN- octinoxate lotion

Yves Saint Laurent All Hours Foundation Flawless Coverage Broad Spectrum SPF 20 Sunscreen by

Drug Labeling and Warnings

Yves Saint Laurent All Hours Foundation Flawless Coverage Broad Spectrum SPF 20 Sunscreen by is a Otc medication manufactured, distributed, or labeled by SICOS ET CIE. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Octinoxate 3%

Purpose

Sunscreen

Uses

• helps prevent sunburn
• if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only

Flammable until dry.

Avoid fire, flame and heat during application.

Do not use

on damaged or broken skin

When using this product

keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

rash occurs

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

• shake well before use
• apply liberally 15 minutes before sun exposure
• reapply at least every 2 hours
• use a water resistant sunscreen if swimming or sweating
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:

•                 limit time in the sun, especially from 10 a.m. - 2 p.m.

•                 wear long-sleeved shirts, pants, hats and sunglasses

• children under 6 months of age: Ask a doctor

Other information

• protect the product in this container from excessive heat and direct sun
  

Inactive ingredients

water, cyclopentasiloxane, alcohol denat., isododecane, acrylates/polytrimethylsiloxymethacrylate copolymer, butylene glycol, glycerin, polymethylsilsesquioxane, cetyl PEG/PPG-10/1 dimethicone, synthetic fluorphlogopite, isohexadecane, polyglyceryl-4 isostearate, magnesium sulfate, disodium stearoyl glutamate, fragrance, perlite, saccharomyces/xylinum/black tea ferment, silica silylate, aluminum hydroxide, butyrospermum parkii (shea) seedcake extract, hydroxyethylcellulose, BHT, phenoxyethanol, sodium citrate, benzyl alcohol, linalool, citric acid, potassium sorbate, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, biotin; may contain: titanium dioxide, iron oxides

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

YVES SAINT LAURENT ALL HOURS FOUNDATION FLAWLESS COVERAGE BROAD SPECTRUM SPF 20 SUNSCREEN 
octinoxate lotion

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 51150-363
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51)	Octinoxate	30 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
CYCLOMETHICONE 6 (UNII: XHK3U310BA)
ALCOHOL (UNII: 3K9958V90M)
ISODODECANE (UNII: A8289P68Y2)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
GLYCERIN (UNII: PDC6A3C0OX)
POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2) (UNII: V2W71V8T0X)
ISOHEXADECANE (UNII: 918X1OUF1E)
POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)
MAGNESIUM SULFATE, UNSPECIFIED FORM (UNII: DE08037SAB)
DISODIUM STEAROYL GLUTAMATE (UNII: 45ASM2L11M)
PERLITE (UNII: 0SG101ZGK9)
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%) (UNII: R33S7TK2EP)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
BENZYL ALCOHOL (UNII: LKG8494WBH)
LINALOOL, (+/-)- (UNII: D81QY6I88E)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS)
BIOTIN (UNII: 6SO6U10H04)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
FERRIC OXIDE RED (UNII: 1K09F3G675)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 51150-363-01	1 in 1 CARTON	06/01/2017	02/16/2025
1		25 mL in 1 BOTTLE; Type 0: Not a Combination Product
2	NDC: 51150-363-02	125 mL in 1 BOTTLE; Type 0: Not a Combination Product	06/01/2017	12/30/2024
3	NDC: 51150-363-03	1 in 1 CARTON	06/01/2017	12/30/2024
3		10 mL in 1 BOTTLE; Type 0: Not a Combination Product
4	NDC: 51150-363-04	1 in 1 CARTON	06/01/2017	12/30/2024
4		5 mL in 1 BOTTLE; Type 0: Not a Combination Product
5	NDC: 51150-363-05	1 mL in 1 PACKET; Type 0: Not a Combination Product	06/01/2017	12/30/2024
6	NDC: 51150-363-06	1.2 mL in 1 BLISTER PACK; Type 0: Not a Combination Product	02/08/2019	12/30/2024
7	NDC: 51150-363-07	1 in 1 CARTON	07/30/2020	12/30/2024
7		8 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	06/01/2017	02/16/2025

Labeler - SICOS ET CIE (276993581)

Establishment
Name	Address	ID/FEI	Business Operations
SICOS ET CIE		276993581	manufacture(51150-363) , pack(51150-363)